Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,738.00
Bid: 1,744.00
Ask: 1,745.00
Change: 6.00 (0.35%)
Spread: 1.00 (0.057%)
Open: 1,732.00
High: 1,749.00
Low: 1,732.00
Prev. Close: 1,732.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Smiths Group - Capital Markets Day 2022

10 Nov 2022 07:00

RNS Number : 9050F
Smiths Group PLC
10 November 2022
 

News Release

10 November 2022

 

 

SMITHS GROUP PLC - CAPITAL MARKETS EVENT

Pioneers of progress - improving our world through smarter engineering

 

Progress on our growth strategy highlighting Flex-Tek, Smiths Interconnect and Sustainability at Smiths

 

Smiths Group plc ("Smiths" or "the Group") announces that it will host a capital markets event today at the Tate Modern in London, with an in-person Q&A session and interactive product exhibition. Presentations are now available to view online and the Q&A will be streamed live at 16.00 GMT on the Smiths website at www.smiths.com/capital-markets-event-2022.

 

Following last year's event, which outlined how the Group will accelerate growth and strengthen execution through the Smiths Value Engine, this year's event will be focused on how the Group is progressing on this strategy with a particular focus on Flex-Tek and Smiths Interconnect and how Sustainability has a pivotal role in accelerating growth.

 

The capital markets event will be led by Smiths Group CEO, Paul Keel and will feature presentations from the Presidents of Flex-Tek, Pat McCaffrey and Smiths Interconnect, Julian Fagge, as well as the Group's Chief Sustainability Officer, John Ostergren, and Group CFO, Clare Scherrer.

 

The Group published its first quarter trading update (available here) covering the three months to the end of October 2022 on 9 November 2022 demonstrating further progress on the strategy, posting organic revenue growth of 13.2%, and reiterating its full year guidance of 4.0-4.5% organic revenue growth for the year with moderate margin improvement. No material update on trading will be provided during the event.

 

Paul Keel, Group Chief Executive, commented:

"Our global team has accomplished a great deal since outlining our strategy last fall and we will give more detail on that accelerating progress today as well as our path to delivering on our medium-term targets.

 

Following a strong FY22, and a strong start to FY23 with six consecutive quarters of growth, we're building a credible track-record. We're grounded in our purpose, powered by our strengths and focused on our three main priorities of Growth, Execution and People. Together this will help us create long term sustainable value for all our stakeholders."

 

Investor enquiries

Media enquiries

 

Jemma Spalton, Smiths Group+44 (0)7867 390 350jemma.spalton@smiths.com

 

Tom Steiner, Smiths Group

+44 (0)7787 415 891

tom.steiner@smiths.com

 

Stephanie Heathers, Smiths Group

+44 (0)7584 113 633

stephanie.heathers@smiths.com

 

Alex Le May, FTI Consulting+44 (0)7702 443 312smiths@fticonsulting.com

 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

About Smiths Group

For over 170 years, Smiths Group has been pioneering progress by improving the world through smarter engineering. We serve millions of people every year, to help create a safer, more efficient and better-connected world, across four major global markets: Energy, General Industry, Safety & Security and Aerospace. Listed on the London Stock Exchange, Smiths employs over 14,700 colleagues in over 50 countries. For more information visit www.smiths.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKLFBLFLXFBZ
Date   Source Headline
17th Nov 20212:40 pmRNSResult of Meeting
17th Nov 20212:35 pmRNSResult of AGM
17th Nov 20212:00 pmRNSSmiths Group Capital Markets Event 2021
11th Nov 20217:00 amRNSSmiths Group Q1 Trading Statement
5th Nov 20211:54 pmRNSDirector/PDMR Shareholding
1st Nov 20215:31 pmRNSDirector/PDMR Shareholding
1st Nov 202111:00 amRNSBlock listing Interim Review
1st Nov 202111:00 amRNSTotal Voting Rights
29th Oct 202112:35 pmRNSNotice of GM
19th Oct 20219:23 amRNSAnnual Financial Report
14th Oct 20212:58 pmRNSDirector/PDMR Shareholding
14th Oct 202112:15 pmRNSDirector/PDMR Shareholding
4th Oct 20214:54 pmRNSDirector/PDMR Shareholding
4th Oct 20213:36 pmRNSDirector/PDMR Shareholding
1st Oct 20211:30 pmRNSTotal Voting Rights
29th Sep 202112:34 pmRNSDirector/PDMR Shareholding
29th Sep 202112:33 pmRNSDirector/PDMR Shareholding
28th Sep 20217:01 amRNSSmiths signs binding agreement to sell Medical
28th Sep 20217:00 amRNSSmiths Group plc Annual Results FY2021
17th Sep 202111:37 amRNSResult of Meeting
8th Sep 20217:00 amRNSSuperior transaction for sale of Smiths Medical
1st Sep 202111:00 amRNSTotal Voting Rights
31st Aug 20211:34 pmRNSCircular re: proposed sale of Smiths Medical
4th Aug 20219:48 amRNSDirector/PDMR Shareholding
2nd Aug 20215:00 pmRNSProposed Sale of Smiths Medical
2nd Aug 202111:33 amRNSDirector/PDMR Shareholding
2nd Aug 202111:00 amRNSTotal Voting Rights
1st Jul 202110:40 amRNSTotal Voting Rights
1st Jun 202112:30 pmRNSTotal Voting Rights
25th May 20217:00 amRNSAppointment of CEO
4th May 20214:27 pmRNSDirector/PDMR Shareholding
4th May 202111:20 amRNSTotal Voting Rights
23rd Apr 20218:00 amRNSAdditional Listing
1st Apr 202110:00 amRNSTotal Voting Rights
26th Mar 20217:00 amRNSSmiths Group plc Interim Results 2021
1st Mar 202112:05 pmRNSTotal Voting Rights
3rd Feb 202111:10 amRNSHolding(s) in Company
1st Feb 202112:20 pmRNSTotal Voting Rights
1st Feb 202112:19 pmRNSDirector/PDMR Shareholding
4th Jan 20214:08 pmRNSTotal Voting Rights
23rd Dec 20201:24 pmRNSHolding(s) in Company - Replacement
16th Dec 20205:17 pmRNSHolding(s) in Company
1st Dec 202010:00 amRNSTotal Voting Rights
19th Nov 20209:03 amRNSDirectorate Change
16th Nov 20204:30 pmRNSResult of AGM
16th Nov 20207:00 amRNSSmiths Group Q1 Trading Statement
4th Nov 20204:41 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:36 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:01 amRNSBlock listing Interim Review
2nd Nov 202010:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.